Table 2 Comparison of subjects PARL, MMSE, and Age between PD patients and healthy people.

From: PARL stabilizes mitochondrial BCL-2 via Nur77-mediated scaffolding as a therapeutic strategy for Parkinson’s disease

Variable

PD

Control

t

p

PARL (pg/ml)

51.90 ± 1.17a

60.04 ± 1.29

4.642

<0.001

MMSE

20.62 ± 0.76a

26.82 ± 0.32

7.482

<0.001

Age

66.42 ± 1.41

67.86 ± 1.29

0.571

0.568

  1. (Mean ± SEM).
  2. aCompared with the Control group, p < 0.001.
Back to article page